Campaign launched to alert healthcare consumers of the two recalls of drug-infusion ports manufactured by Boston Scientific Corp. and the potential class action lawsuit to recover damages.
Wilmington, NC (PRWEB) June 30, 2005 -- After formal warning from the FDA, and a major product recall by Boston Scientific Corporation, Greg Jones & Associates, a North Carolina-based law firm, in association with launches a campaign to gather plaintiffs for a potential class action lawsuit.
Boston Scientific Corp. has voluntarily recalled over 2,000 of their drug-infusion devices due to reports of drug leakage and device breakage. These medical devices are surgically implanted under the skin and deliver drugs, such as chemotherapy, through a catheter that is attached to a vein.
After careful investigation, both the FDA and Boston Scientific Corp. recognize major problems with manufacturing and quality control regulations. Boston Scientific is preparing for multi-million dollar fines as it recommends that patients visit their doctor to have these implants surgically removed. Last year, Boston Scientific announced three product recalls for similar manufacturing problems with their popular cardiac stents.
Boston Scientific Corporation, based in Natick, Massachusetts, is a worldwide medical device giant with 16,000 employees and $5.6 billion in annual revenues.
This medical product developer and manufacturer also creates devices such as balloon catheters, stents, sheaths, implantable ports, and medical imaging tools.
Greg Jones & Associates is urging patients that have experienced problems or device malfunctions with Boston Scientifics valved and nonvalved ports, such as the Vaxcel Low Profile Infusion Port.